Proinflammatory adaptive cytokine and shed tumor necrosis factor receptor levels are elevated preceding systemic lupus erythematosus disease flare.
American College of Rheumatology criteria at inception, and accrual over 5 years in the SLICC inception cohort.
Two functional lupus-associated BLK promoter variants control cell-type- and developmental-stage-specific transcription.
Disease control and safety of belimumab plus standard therapy over 7 years in patients with systemic lupus erythematosus.
